Skip to main content
Caplight Logo









ReNewVax Ltd.

ReNewVax Ltd.

Private
LiverpoolHealthcare & Life Scienceshttps://renewvax.com/

Last Round

Series A

Nov 6, 2025

Total Funding Raised

$3.3M

Company Overview

ReNewVax Ltd. is a biotechnology company that develops novel protein-based vaccines targeting bacterial infections and antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyvaccine developmentantimicrobial resistanceAMRreverse vaccinologyprotein-based vaccinedrug discoveryuniversal vaccinebioinformaticsbiotech startuppneumococcal vaccinevaccine pipelinegenomicsdrug licensingpre-clinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ReNewVax Ltd. Comparables

Compare ReNewVax Ltd. with similar companies based on industry and business-model similarity.

ReNewVax Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GPN Vaccines
83%
Inventprise
77%
i-Seq Biotechnology
75%

ReNewVax Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 6, 2025
SeedAug 8, 2025

ReNewVax Ltd. Investors

Notable investors and investment history

ReNewVax Ltd. investors
InvestorRounds
QUBISSeed
Innovate UKSeed
LYVA LabsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 38% MoM.

  • Apr 7, 2026

    Monthly visitors increased 316% MoM.

ReNewVax Ltd. Filings

Explore SEC and related filing metadata, where available.

ReNewVax Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ReNewVax Ltd.'s valuation, stock price, and market status.

Is ReNewVax Ltd. a public or private company?

ReNewVax Ltd. is a private company.

What is the current stock price of ReNewVax Ltd.?

ReNewVax Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is ReNewVax Ltd. worth (valuation)?

Valuation information for ReNewVax Ltd. is not publicly available.

Can I buy ReNewVax Ltd. stock?

ReNewVax Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ReNewVax Ltd.'s last funding round?

ReNewVax Ltd.'s most recent funding round was Series A on November 6, 2025.

Who are the main investors in ReNewVax Ltd.?

Key investors in ReNewVax Ltd. include QUBIS, Innovate UK, LYVA Labs.

Will ReNewVax Ltd. IPO soon?

No public IPO plans have been announced for ReNewVax Ltd..

How can I track ReNewVax Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ReNewVax Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLiverpool
Employee Range5
Year Founded2022
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?